Eboni Ife Lance, M.D.

Headshot of Eboni Ife Lance
  • Medical Director of the Sickle Cell Neurodevelopmental Clinic
  • Associate Professor of Neurology

Specializes in: Adolescents (12-18 years), Children (1-11 years), Infants (up to 1 year)


Attention Deficit Hyperactivity Disorder (ADHD), Intellectual Disability, Learning Disabilities, Neurodevelopmental Disorders, Pediatric Sickle Cell Disease ...read more


Kennedy Krieger Institute

Appointment Phone: 443-923-2608
801 N. Broadway
Baltimore, MD 21205 map
Phone: 443-923-9150 | Fax: 443-923-9540


Dr. Lance received her undergraduate degree from Princeton University and received her medical degree from the Medical University of South Carolina. She did residency in general pediatrics at Childrens Hospital Los Angeles and additional specialized residency training in neurodevelopmental disabilities at the Kennedy Krieger Institute. She received additional research training at Kennedy Krieger Institute/Johns Hopkins University School of Medicine and has a Ph.D. in clinical investigation from the Johns Hopkins Bloomberg School of Public Health.

...read more


  • Medical Director of the Sickle Cell Neurodevelopmental Clinic
  • Associate Professor of Neurology

Departments / Divisions



  • M.D.; Medical University of South Carolina College of Medicine (Charleston) (South Carolina) (2007)
  • A.B.; Princeton University (New Jersey) (2003)

Additional Training

  • American Board of Psychiatry and Neurology
  • American Board of Pediatrics

Research & Publications

Selected Publications

Lance EI, Comi AM, Johnston MV, Casella JF, Shapiro, BK.  Risk Factors for Attention and Behavioral Issues in Pediatric Sickle Cell Disease.  Clin Pediatr ahead of print 2015 Jul 6.

Gipson TT*, Lance EI*, (*co-first authors), Albury RA, Gentner MB, Leppert ML. Disparities in Identification of Comorbid Diagnoses in Children with ADHD.  Clin Pediatr 2015 54(4):376-81.

Lance EI, Casella JF, Everett AD, Barron-Casella E.  Proteomic and Biomarker Studies and Neurological Complications of Pediatric Sickle Cell Disease.  Proteomics Clin Appl 2014 8(11-12):813-27.

Lance EI, Lanier K, Zabel TA, Comi AM.  Stimulant Use in Patients with Sturge-Weber Syndrome: Safety and Efficacy.  Ped Neurol 2014 51(5): 675-680.

Lance EI, York, JM, Lee LC, Zimmerman, AW. Association between Regression and Self Injury among Children with Autism.  Res Dev Disabil 2014 35(2): 408 – 413.

Lance EI*, Sreenivasan AK*, (*co-first authors), Zabel TA, Kossof EH, Comi AM.  Aspirin Use in
Sturge-Weber Syndrome: Side Effects and Clinical Outcomes.  J Child Neurol 2013 28(2): 213-218.

Lance EI, Shapiro BK.  Confounding Diagnoses in the Neurodevelopmental Disabilities Population: A child with Hearing Loss, Absence Epilepsy, and Attention Deficit Hyperactivity Disorder.  J Child Neurol 2013 28(5): 645 – 647.

Lance EI, Dupont BR, Holden KR. Expansion of the Deletion 13q Syndrome Phenotype: A Case Report.  J Child Neurol 2007 22(9): 1124-1127.

Activities & Honors


  • American Academy of Neurology
  • Child Neurology Society
  • American Academy of Pediatrics
  • American Society of Hematology

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

Is this you? Edit Profile
back to top button